It's interesting, sure. Still very early stage pre-clinical in the lab, basically in petri dishes. Maybe try further again and into mice next year ? Along with the other proposed mouse models in 2018. FWIW when ever people are banging on about "cure for cancer" is more hurt than good imo - and in petri-dishes that's not anything new, plenty of people / companies can cure cancer in a petri dish or test tube. PARP inhibitors are a hot space although we already knew that and they thought they would work synergistically with inhibitors like parp.
Further animal models should be interesting in 2018
Ann: PAT-DX1 Conjugated to Nanoparticles, Targets Tumors, page-122
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
-0.001(12.5%) |
Mkt cap ! $14.40M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.7¢ | 0.7¢ | $87 | 12.47K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 8089083 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 2630083 | 4 |
View Market Depth
| Last trade - 14.01pm 05/06/2024 (20 minute delay) ? |
|
|||||
|
Last
0.7¢ |
Change
-0.001 ( 6.67 %) |
||||
| Open | High | Low | Volume | ||
| 0.7¢ | 0.7¢ | 0.7¢ | 1424710 | ||
| Last updated 15.24pm 05/06/2024 ? | |||||
| PAB (ASX) Chart |